Procedure for use of Signaling Multiplex Panels 4-5 (MEK/ERK) for the Analysis of Clinical Tumor Biopsy Extracts and Reporting of Data
BRD ID: 3028
Tier: SOP
Source: DCTD
Number of times downloaded: 306
Description
This document describes the procedures for the quantification of analytes by multiplex immunoassays, specifically the Luminex platform in conjunction with Total and Phospho MEK/ERK Panels, for pharmacodynamic studies. It is a product of the National Cancer Institute's (NCI) Division of Cancer Treatment and Diagnosis (DCTD; https://dctd.cancer.gov/). Please check the DCTD website (https://dctd.cancer.gov/drug-discovery-development/assays) for the current SOP version.
Biospecimens
TissueNot specified
Diagnoses
NeoplasticNot specified
Topics
Platform-specific Methodology